Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Aligos Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- −21 vs. Q2 2024
- Shares held
- 1.69M
- −190.5K (−10.1%) vs. Q2 2024Converted for a 1-for-25 split
- Total value
- $14.7M
- −$1.82M (−11.0%) vs. Q2 2024
- New holders
- 3
- 8 more added
- Sold out
- 24
- 7 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.2M |
| Q1 2026 | 35 | $20.6M |
| Q4 2025 | 41 | $26.2M |
| Q3 2025 | 33 | $26.0M |
| Q2 2025 | 37 | $19.5M |
| Q1 2025 | 35 | $27.1M |
| Q4 2024 | 34 | $64.5M |
| Q3 2024 | 27 | $14.7M |
| Q2 2024 | 49 | $16.6M |
| Q1 2024 | 49 | $45.3M |
| Q4 2023 | 40 | $30.1M |
| Q3 2023 | 36 | $19.2M |
| Q2 2023 | 41 | $25.5M |
| Q1 2023 | 46 | $23.9M |
| Q4 2022 | 39 | $25.3M |
| Q3 2022 | 52 | $30.4M |
| Q2 2022 | 60 | $36.0M |
| Q1 2022 | 76 | $68.4M |
| Q4 2021 | 71 | $390.4M |
| Q3 2021 | 68 | $483.9M |
| Q2 2021 | 58 | $550.5M |
| Q1 2021 | 52 | $612.4M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 315,095 | $2.73M | 0.07% | +24,839+8.6% | AddedConverted for a 1-for-25 split |
| EcoR1 Capital, LLC | 255,573 | $2.21M | 0.08% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Deep Track Capital, LP | 244,110 | $2.11M | 0.07% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Adage Capital Partners GP, L.L.C. | 218,813 | $1.89M | 0.00% | +18,813+9.4% | AddedConverted for a 1-for-25 split |
| Vivo Capital, LLC | 141,879 | $1.23M | 0.10% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Woodline Partners LP | 91,971 | $796.5K | 0.01% | +70,723+332.8% | AddedConverted for a 1-for-25 split |
| Baker Bros. Advisors LP | 83,055 | $719.3K | 0.01% | 00.0% | UnchangedConverted for a 1-for-25 split |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 76,247 | $660.3K | 0.01% | −48,621−38.9% | ReducedConverted for a 1-for-25 split |
| UBS Oconnor LLC | 67,096 | $581.1K | 0.01% | +27,096+67.7% | AddedConverted for a 1-for-25 split |
| Vanguard Group Inc | 63,814 | $552.6K | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Acadian Asset Management LLC | 30,597 | $263.0K | 0.00% | −2,582−7.8% | ReducedConverted for a 1-for-25 split |
| Silverarc Capital Management, LLC | 26,219 | $227.1K | 0.05% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Geode Capital Management, LLC | 24,056 | $208.4K | 0.00% | +7,828+48.2% | AddedConverted for a 1-for-25 split |
| Renaissance Technologies LLC | 13,443 | $116.4K | 0.00% | −17,311−56.3% | ReducedConverted for a 1-for-25 split |
| Charles Schwab Investment Management Inc | 11,980 | $103.7K | 0.00% | +10,725+854.3% | AddedConverted for a 1-for-25 split |
| Qube Research & Technologies Ltd | 10,947 | $94.8K | 0.00% | +10,947+13,683,650.0% | AddedConverted for a 1-for-25 split |
| BlackRock, Inc. | 9,067 | $78.5K | 0.00% | +9,067 | New |
| Bank of America Corp | 6,851 | $59.3K | 0.00% | −25,790−79.0% | ReducedConverted for a 1-for-25 split |
| CWM, LLC | 675 | $6.00K | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Advisor Group Holdings, Inc. | 220 | $1.91K | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Morgan Stanley | 134 | $1.16K | 0.00% | +2+1.5% | AddedConverted for a 1-for-25 split |
| AlphaMark Advisors, LLC | 100 | $1.00K | 0.00% | +100 | New |
| Tower Research Capital LLC (TRC) | 30 | $260 | 0.00% | −1,829−98.4% | ReducedConverted for a 1-for-25 split |
| JPMorgan Chase & Co | 26 | $225 | 0.00% | −1−4.0% | ReducedConverted for a 1-for-25 split |
| UBS Group AG | 14 | $121 | 0.00% | −0−3.3% | ReducedConverted for a 1-for-25 split |
| ZRC Wealth Management, LLC | 4 | $35 | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| BNP Paribas Arbitrage, SA | 3 | $26 | 0.00% | +3 | New |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −66,000−100.0% | Sold outConverted for a 1-for-25 split |
| Versant Venture Management, LLC | 0 | $0 | 0.00% | −58,317−100.0% | Sold outConverted for a 1-for-25 split |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −50,400−100.0% | Sold outConverted for a 1-for-25 split |
| Pivotal bioVenture Partners Investment Advisor LLC | 0 | $0 | 0.00% | −29,729−100.0% | Sold outConverted for a 1-for-25 split |
| Newtyn Management, LLC | 0 | $0 | 0.00% | −28,771−100.0% | Sold outConverted for a 1-for-25 split |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −11,369−100.0% | Sold outConverted for a 1-for-25 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −11,095−100.0% | Sold outConverted for a 1-for-25 split |
| State Street Corp | 0 | $0 | 0.00% | −4,285−100.0% | Sold outConverted for a 1-for-25 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −3,678−100.0% | Sold outConverted for a 1-for-25 split |
| LMR Partners LLP | 0 | $0 | 0.00% | −2,000−100.0% | Sold outConverted for a 1-for-25 split |
| XTX Topco Ltd | 0 | $0 | 0.00% | −1,426−100.0% | Sold outConverted for a 1-for-25 split |
| Millennium Management LLC | 0 | $0 | 0.00% | −1,195−100.0% | Sold outConverted for a 1-for-25 split |
| Choate Investment Advisors | 0 | $0 | 0.00% | −960−100.0% | Sold outConverted for a 1-for-25 split |
| Prudential Financial Inc | 0 | $0 | 0.00% | −784−100.0% | Sold outConverted for a 1-for-25 split |
| HarbourVest Partners LLC | 0 | $0 | 0.00% | −751−100.0% | Sold outConverted for a 1-for-25 split |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −748−100.0% | Sold outConverted for a 1-for-25 split |
| ZWJ Investment Counsel Inc | 0 | $0 | 0.00% | −580−100.0% | Sold outConverted for a 1-for-25 split |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −547−100.0% | Sold outConverted for a 1-for-25 split |
| Zullo Investment Group, Inc. | 0 | $0 | 0.00% | −520−100.0% | Sold outConverted for a 1-for-25 split |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −400−100.0% | Sold outConverted for a 1-for-25 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −492−100.0% | Sold outConverted for a 1-for-25 split |
| Creative Planning | 0 | $0 | 0.00% | −402−100.0% | Sold outConverted for a 1-for-25 split |
| Royal Bank of Canada | 0 | $0 | 0.00% | −20−100.0% | Sold outConverted for a 1-for-25 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold outConverted for a 1-for-25 split |
| BlackRock Inc. | – | – | – | – | Not filed |